Serum IL-33 and sST2 have been associated with more severe autoimmune diseases (i.e., Sjögren’s disease, myocarditis), asthma, and cancers, but use of knockout mice and recombinant protein or blocking antibody in animal models have yielded conflicting results (13–15). Here, IL33 is linked to asthma.